EQS consultants provide comprehensive FDA compliance services to the Bio Tech, pharmaceutical, and medical device industries.
EQS staff performs audits and gaps analysis, pre-assessments, and preparation for certification, and develops training protocols.
Through customized approaches that suit your individual needs and cost-effective project management, EQS develops plans and procedures that meet FDA compliance for electronic record criteria under 21 CFR Part 11 for cGMP, GLP and GCP.
EQS provides Bio Tech FDA compliance and regulatory affairs consulting.
Integrating customized implementation of 510(k), cGMP and GCP and process control with BioTech FDA compliance criteria and goals, EQS delivers audit support for domestic and international standards.
We can assist you in response to 483's, warning letters, consent decrees and import detentions.
EQS dynamic staff of responsive compliance experts deliver consistent and effective results. Taking rapidly changing developments in to consideration, they provide innovative solutions that reach into the future.
Stem Cell Research
Even privately funded stem cell
research is subject to federal law and regulation.
EQS offers the strategic compliance planning to ensure that
and commercial ventures will not be impaired by undue regulatory constraints
|Northern California Offices:
760 Market Street
San Francisco, CA 94102
Tel: 415/986-8064 Fax: 415/986-8068
|Southern California Offices:
Suite 101 130 McCormick Avenue
Costa Mesa, Ca 92626
Tel: 949-733-3116 Fax: 714-437-0299